Canada markets closed

PharmaTher Holdings Ltd. (PHRM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.6100+0.0200 (+3.39%)
At close: 3:59PM EDT

PharmaTher Holdings Ltd.

West Georgia Street
Suite 1055 1500 Royal Centre P.O. Box 11117
Vancouver, BC V6E 4N7
Canada

http://www.pharmather.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Fabio ChianelliCEO & ChairmanN/AN/A1978
Mr. Carmelo Marrelli ACIS, B.Comm., CA, CGA, CPAChief Financial OfficerN/AN/A1971
Mr. Andrew ToddCorp. Sec.N/AN/A1958
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's products in pipeline include Ketamine, which is in Phase I and II clinical trials for Parkinson's disease indications, as well as in preclinical trials for ALS-Lou Gehrig's disease indications; and KETABET, which is in Phase I and II clinical trials for mental health, neurological, and pain disorders. It is also developing microneedle patches for the delivery of antivirals for the treatment of influenza; and NCEs for multiple indications. The company is headquartered in Vancouver, Canada.

Corporate Governance

PharmaTher Holdings Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.